Henan Lingrui Pharmaceutical Co Ltd (600285) — Working Capital to Net Assets Ratio
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Working Capital to Net Assets ratio of 10.2% as of March 2026. Working capital of CN¥375.24 Million (current assets of CN¥2.57 Billion minus current liabilities of CN¥2.19 Billion) is measured against net assets of CN¥3.69 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Henan Lingrui Pharmaceutical Co Ltd (600285) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Henan Lingrui Pharmaceutical Co Ltd Working Capital to Net Assets (1997–2025)
This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 10.2%, reflecting working capital of CN¥375.24 Million against net assets of CN¥3.69 Billion CNY. For the complete balance sheet picture, see balance sheet size of Henan Lingrui Pharmaceutical Co Ltd.
Annual Working Capital to Net Assets for Henan Lingrui Pharmaceutical Co Ltd (1997–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Henan Lingrui Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 4.8% | CN¥164.31 Million | CN¥3.44 Billion | CN¥2.28 Billion | CN¥2.12 Billion | ▼ -14.2 pp |
| 2024 | 18.9% | CN¥583.70 Million | CN¥3.08 Billion | CN¥2.46 Billion | CN¥1.87 Billion | ▼ -6.0 pp |
| 2023 | 25.0% | CN¥698.77 Million | CN¥2.80 Billion | CN¥2.60 Billion | CN¥1.90 Billion | ▼ -6.2 pp |
| 2022 | 31.1% | CN¥796.44 Million | CN¥2.56 Billion | CN¥2.51 Billion | CN¥1.71 Billion | ▲ +0.8 pp |
| 2021 | 30.3% | CN¥693.59 Million | CN¥2.29 Billion | CN¥2.13 Billion | CN¥1.44 Billion | ▼ -6.3 pp |
| 2020 | 36.6% | CN¥850.28 Million | CN¥2.32 Billion | CN¥1.92 Billion | CN¥1.07 Billion | ▲ +3.3 pp |
| 2019 | 33.4% | CN¥740.57 Million | CN¥2.22 Billion | CN¥1.75 Billion | CN¥1.01 Billion | ▲ +2.2 pp |
| 2018 | 31.1% | CN¥652.19 Million | CN¥2.09 Billion | CN¥1.59 Billion | CN¥942.62 Million | ▲ +3.6 pp |
| 2017 | 27.6% | CN¥607.74 Million | CN¥2.20 Billion | CN¥1.62 Billion | CN¥1.01 Billion | ▼ -10.6 pp |
| 2016 | 38.2% | CN¥806.12 Million | CN¥2.11 Billion | CN¥1.56 Billion | CN¥756.72 Million | ▲ +29.0 pp |
| 2015 | 9.1% | CN¥157.39 Million | CN¥1.72 Billion | CN¥942.57 Million | CN¥785.18 Million | ▲ +5.2 pp |
| 2014 | 4.0% | CN¥61.86 Million | CN¥1.56 Billion | CN¥820.69 Million | CN¥758.83 Million | ▼ -23.1 pp |
| 2013 | 27.0% | CN¥266.39 Million | CN¥984.89 Million | CN¥839.55 Million | CN¥573.17 Million | ▲ +14.4 pp |
| 2012 | 12.7% | CN¥88.48 Million | CN¥696.97 Million | CN¥575.33 Million | CN¥486.85 Million | ▼ -9.3 pp |
| 2011 | 22.0% | CN¥150.32 Million | CN¥684.01 Million | CN¥577.57 Million | CN¥427.25 Million | ▼ -3.3 pp |
| 2010 | 25.3% | CN¥179.46 Million | CN¥709.69 Million | CN¥571.07 Million | CN¥391.61 Million | ▲ +11.5 pp |
| 2009 | 13.8% | CN¥89.02 Million | CN¥645.69 Million | CN¥436.39 Million | CN¥347.37 Million | ▼ -3.1 pp |
| 2008 | 16.9% | CN¥92.95 Million | CN¥549.72 Million | CN¥505.37 Million | CN¥412.42 Million | ▼ -10.3 pp |
| 2007 | 27.2% | CN¥157.53 Million | CN¥579.24 Million | CN¥488.32 Million | CN¥330.79 Million | ▲ +1.7 pp |
| 2006 | 25.5% | CN¥124.14 Million | CN¥486.67 Million | CN¥500.40 Million | CN¥376.26 Million | ▼ -23.0 pp |
| 2005 | 48.5% | CN¥232.62 Million | CN¥479.80 Million | CN¥489.58 Million | CN¥256.96 Million | ▲ +5.9 pp |
| 2004 | 42.6% | CN¥199.77 Million | CN¥469.45 Million | CN¥451.64 Million | CN¥251.87 Million | ▼ -5.7 pp |
| 2003 | 48.2% | CN¥217.78 Million | CN¥451.69 Million | CN¥395.98 Million | CN¥178.19 Million | ▼ -0.6 pp |
| 2002 | 48.8% | CN¥203.43 Million | CN¥416.74 Million | CN¥400.05 Million | CN¥196.63 Million | ▼ -21.2 pp |
| 2001 | 70.0% | CN¥281.23 Million | CN¥401.79 Million | CN¥366.74 Million | CN¥85.50 Million | ▼ -18.6 pp |
| 2000 | 88.6% | CN¥362.00 Million | CN¥408.46 Million | CN¥426.74 Million | CN¥64.73 Million | ▲ +40.0 pp |
| 1999 | 48.6% | CN¥30.20 Million | CN¥62.08 Million | CN¥126.89 Million | CN¥96.70 Million | ▼ -22.4 pp |
| 1998 | 71.0% | CN¥35.42 Million | CN¥49.85 Million | CN¥80.91 Million | CN¥45.49 Million | ▲ +10.3 pp |
| 1997 | 60.8% | CN¥20.65 Million | CN¥33.98 Million | CN¥54.52 Million | CN¥33.87 Million | — |